Pneumovax 23 (Pneumococcal vaccine polyvalent) Injectable Solution
- RxCUI
- 854981
- RxNorm name
- Pneumovax 23 (Pneumococcal vaccine polyvalent) Injectable Solution
- Display name
- Pneumovax 23 (Pneumococcal vaccine polyvalent) Injectable Solution
- Full name
- Pneumovax 23 (Pneumococcal vaccine polyvalent) Injectable Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:18
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 101094 | Pneumovax 23 | Pneumococcal Vaccine, Polyvalent | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| bb362a20-6d91-4ae8-bebb-9ee8b2591814 | PNEUMOVAX 23 vaccine Injectable Solution [PSN] · Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 12F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 14 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 15B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 17F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 18C capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19A capsular polysaccharide antigen 0.05 [SBD] · Pneumovax 23 (Pneumococcal vaccine polyvalent) Injectable Solution [SY] | 3 | 34 | These highlights do not include all the information needed to use PNEUMOVAX 23 safely and effectively. See full prescribing information for PNEUMOVAX 23. PNEUMOVAX® 23 (pneumococcal vaccine polyvalent) Sterile, Liquid Vaccine for Intramuscular or Subcutaneous Injection Initial U.S. Approval: 1983 | 20241024 |